GB202108170D0 - Theraputic inhibitors of GDF15 Signalling - Google Patents

Theraputic inhibitors of GDF15 Signalling

Info

Publication number
GB202108170D0
GB202108170D0 GBGB2108170.8A GB202108170A GB202108170D0 GB 202108170 D0 GB202108170 D0 GB 202108170D0 GB 202108170 A GB202108170 A GB 202108170A GB 202108170 D0 GB202108170 D0 GB 202108170D0
Authority
GB
United Kingdom
Prior art keywords
theraputic
gdf15
signalling
inhibitors
theraputic inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2108170.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kymab Ltd
Original Assignee
Kymab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kymab Ltd filed Critical Kymab Ltd
Priority to GBGB2108170.8A priority Critical patent/GB202108170D0/en
Publication of GB202108170D0 publication Critical patent/GB202108170D0/en
Priority to BR112023020152A priority patent/BR112023020152A2/pt
Priority to KR1020237037287A priority patent/KR20230165285A/ko
Priority to JP2023560403A priority patent/JP2024511853A/ja
Priority to CA3215737A priority patent/CA3215737A1/en
Priority to PCT/EP2022/058669 priority patent/WO2022207846A1/en
Priority to US18/284,952 priority patent/US20240182585A1/en
Priority to IL307382A priority patent/IL307382A/en
Priority to MX2023011655A priority patent/MX2023011655A/es
Priority to EP22720935.0A priority patent/EP4314071A1/en
Priority to AU2022251923A priority patent/AU2022251923A1/en
Priority to CN202280037901.0A priority patent/CN117916262A/zh
Priority to CONC2023/0013791A priority patent/CO2023013791A2/es
Ceased legal-status Critical Current

Links

GBGB2108170.8A 2021-03-31 2021-06-08 Theraputic inhibitors of GDF15 Signalling Ceased GB202108170D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB2108170.8A GB202108170D0 (en) 2021-06-08 2021-06-08 Theraputic inhibitors of GDF15 Signalling
CN202280037901.0A CN117916262A (zh) 2021-03-31 2022-03-31 Gdf15信号传导的治疗性抑制剂
US18/284,952 US20240182585A1 (en) 2021-03-31 2022-03-31 Therapeutic inhibitors of gdf15 signalling
KR1020237037287A KR20230165285A (ko) 2021-03-31 2022-03-31 Gdf15 신호전달의 치료적 억제제
JP2023560403A JP2024511853A (ja) 2021-03-31 2022-03-31 Ｇｄｆ１５シグナル伝達の治療的阻害剤
CA3215737A CA3215737A1 (en) 2021-03-31 2022-03-31 Therapeutic inhibitors of gdf15 signalling
PCT/EP2022/058669 WO2022207846A1 (en) 2021-03-31 2022-03-31 Therapeutic inhibitors of gdf15 signalling
BR112023020152A BR112023020152A2 (pt) 2021-03-31 2022-03-31 Inibidores terapêuticos de sinalização gdf15
IL307382A IL307382A (en) 2021-03-31 2022-03-31 Therapeutic inhibitors of GDF15 signaling
MX2023011655A MX2023011655A (es) 2021-03-31 2022-03-31 Inhibidores terapeuticos de la se?alizacion de gdf15.
EP22720935.0A EP4314071A1 (en) 2021-03-31 2022-03-31 Therapeutic inhibitors of gdf15 signalling
AU2022251923A AU2022251923A1 (en) 2021-03-31 2022-03-31 Therapeutic inhibitors of gdf15 signalling
CONC2023/0013791A CO2023013791A2 (es) 2021-03-31 2023-10-19 Inhibidores terapéuticos de la señalización de gdf15

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2108170.8A GB202108170D0 (en) 2021-06-08 2021-06-08 Theraputic inhibitors of GDF15 Signalling

Publications (1)

Publication Number Publication Date
GB202108170D0 true GB202108170D0 (en) 2021-07-21

Family

ID=76838735

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2108170.8A Ceased GB202108170D0 (en) 2021-03-31 2021-06-08 Theraputic inhibitors of GDF15 Signalling

Country Status (2)

Country Link
CN (1) CN117916262A (zh)
GB (1) GB202108170D0 (zh)

Also Published As

Publication number Publication date
CN117916262A (zh) 2024-04-19

Similar Documents

Publication Publication Date Title
IL281939A (en) VAP-1 inhibitors
IL283592A (en) Apol1 inhibitors and methods of using them
IL287751A (en) kcnt1 inhibitors and methods of use
IL287768A (en) kcnt1 inhibitors and methods of use
ZA202006092B (en) Imidazopiperazine inhibitors of transcription activating proteins
ZA202203770B (en) Pharmaceutical combination of prmt5 inhibitors
IL287973A (en) acss2 inhibitors and methods of their use
GB202003778D0 (en) Use of lactoferrin
GB202103594D0 (en) Antagonist of PCSK9
IL284434A (en) Fibroblast activation protein inhibitors
IL281815A (en) VAP-1 inhibitors
IL288851A (en) Heteroaromatic inhibitors of astacin proteinases
IL308476A (en) Inhibitors of the menin-mil interaction
IL285867A (en) Antisense oligomers for the treatment of conditions and diseases
IL276312A (en) Use of Alkoxypyrazoles as nitrification inhibitors
GB202108170D0 (en) Theraputic inhibitors of GDF15 Signalling
SG11202109700PA (en) Caspase inhibitors and methods of use thereof
PL3722401T3 (pl) Żelowy środek sanitarny dla unikania biofilmu
IL307382A (en) Therapeutic inhibitors of GDF15 signaling
GB202107331D0 (en) Therapeutic inhibitors of GDF15 signalling
GB202104556D0 (en) Therapeutic inhibitors of GDF15 signalling
ZA202200268B (en) Combination therapy of gpr119 agonists and dpp-4 inhibitors
IL283295A (en) gli1 inhibitors as therapeutic agents
EP3968994C0 (en) ABHD12 INHIBITORS AND METHODS FOR THE PRODUCTION AND USE THEREOF
GB201907305D0 (en) Treatment of conditions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)